PFE241129C37000
- 0.00
- 0.000.00%
Pfizer Newsroom
Pfizer and Schlumberger Are January Bounce Candidates
Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
Morgan Stanley Sticks to Their Hold Rating for Pfizer (PFE)
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Express News | Shenzhen Kangtai Biological Products: The 20-valent pneumococcal polysaccharide conjugate vaccine has initiated phase I clinical trials.
Hong Kong stocks fluctuate | zai lab (09688) rises over 5% as it reaches a collaboration in mainland china with pfizer on a new antibacterial drug.
zai lab (09688) rose more than 5%, as of the deadline, up 5.26%, trading at 20.8 Hong Kong dollars, with a turnover of 7.8692 million Hong Kong dollars.
Laurel Lee From Florida's 15th District Makes Notable Trades in Apple, GE Vernova, and Pfizer
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Pfizer Options Spot-On: On November 22nd, 411.31K Contracts Were Traded, With 3.36 Million Open Interest
On November 22nd ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 411.31K options for the day, of which put options accounted for 24.82% of the total transactions, and
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)
Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination
Pfizer Options Spot-On: On November 21st, 265.78K Contracts Were Traded, With 3.35 Million Open Interest
On November 21st ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 265.78K options for the day, of which put options accounted for 47.97% of the total transactions, and
Optimism Over Global Healthcare Sector Rises: Jefferies
Watching Shares Of Vaccine Stocks; Traders Circulate Article Titled "Top FDA Vaccine Official Says RFK Jr. Nomination Is a Chance for Scientist to Make the Case for Vaccines"
Live On CNBC, Josh Brown Announces Cut Pfizer Position By Half
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade